Does peroxisome proliferator-activated receptor-γ activation prevent sepsis-related cardiac dysfunction and mortality in mice?
Activation of PPARγ in LPS-treated mice prevented cardiac dysfunction and mortality, despite development of cardiac inflammation and PPARα downregulation.
We concluded that CPAP treatment during 18 months in patients with an AHI > or = 20 afforded significant protection against new vascular events after ischemic stroke.